cirazoline has been researched along with Diabetes Mellitus, Type 2 in 2 studies
cirazoline: posseses agonist properties at alpha-adrenoreceptor sites; RN given refers to parent cpd
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mita, M | 2 |
| Kuramoto, T | 1 |
| Ito, K | 2 |
| Toguchi-Senrui, N | 1 |
| Hishinuma, S | 1 |
| Walsh, MP | 2 |
| Shoji, M | 2 |
| Taira, K | 1 |
| Nakagawa, J | 1 |
2 other studies available for cirazoline and Diabetes Mellitus, Type 2
| Article | Year |
|---|---|
Impairment of α1-adrenoceptor-mediated contractile activity in caudal arterial smooth muscle from type 2 diabetic Goto-Kakizaki rats.
Topics: Adrenergic alpha-1 Receptor Agonists; Animals; Arteries; Diabetes Mellitus, Type 2; Imidazoles; In V | 2010 |
Attenuation of store-operated Ca2+ entry and enhanced expression of TRPC channels in caudal artery smooth muscle from Type 2 diabetic Goto-Kakizaki rats.
Topics: Adrenergic alpha-Agonists; Animals; Arteries; Calcium; Diabetes Mellitus, Type 2; Enzyme Inhibitors; | 2010 |